Physician profile
Philip Majestro
NPI 1609913755
$2,675.64
in general payments reported to CMS, 2019-2025
11 companies · $52.82 in 2025
The $52.82 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237 · 2020: $254 · 2021: $248 · 2022: $100 · 2023: $186 · 2024: $1,598 · 2025: $52.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $1,303 · Food and Beverage: $268 · Education: $266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $1,302.70 |
| Food and Beverage | $268.27 |
| Education | $265.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Premier Dental Products Company | $1,302.70 | 2024 | Big Easy Insert #10 Universal 30k |
| Dentsply LLC | $385.60 | 2020-2021 | |
| Straumann USA LLC | $242.17 | 2019-2023 | |
| Zimvie INC. | $228.55 | 2024 | |
| Zimmer Biomet Holdings, INC. | $224.20 | 2019-2021 | |
| Gc America INC. | $68.45 | 2023-2025 | Gc Fujicem, Equia, G-Aenial |
| Voco America INC. | $67.00 | 2024 | Admira Fusion X-Tra, Futurabond U, Grandio So |
| Dentsply Sirona INC | $57.50 | 2019-2023 | Midwest E Plus |
| Septodont INC. | $54.01 | 2020 | |
| Philips North America LLC | $26.46 | 2023 | |
| Ultradent Products INC | $19.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Majestro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.